APPLICATION OF ATOMOXETINE HYDROCHLORIDE, PULSE LOW-INTENSITY ELECTROMAGNETIC FIELD AND OXYGEN COCKTAIL IN CHILDREN WITH MINIMAL BRAIN DYSFUNCTION ASSOCIATING HYPERACTIVITY Russian patent published in 2011 - IPC A61N2/04 A61K31/135 A61K33/00 A61P25/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to pediatrics, particularly to neurology, psychiatry, physiotherapy, and can be used for treating children with minimal brain dysfunction associating hyperactivity. That is ensured by introduction of atomoxetine hydrochloride and additional exposure to pulse low-intensity electromagnetic field generated by Infita apparatus. Length of procedure is 5 minutes on the first sessions to be gradually increased to 10 minutes by the 6th procedure and thereafter decreased to 5 minutes to the last procedure; the therapeutic course is 10 procedures. Oxygen cocktail is introduced once a day one hour after infitatherapy.

EFFECT: method provides higher clinical effectiveness, ensuring reduced length of introduction of atomoxetine hydrochloride and respectively reduced by-effects with preserved prolonged stable therapeutic effect.

2 cl, 2 ex, 8 tbl